NC, W., RG, A., DD, S., R, S., NE, P., M, S., . . . JA, C. (2019). Phase III Trial of Intravenous Mannitol Versus Placebo During Nephron-sparing Surgery: Post Hoc Analysis of 3-yr Outcomes. European urology focus, 5(6), 977. https://doi.org/10.1016/j.euf.2019.04.003
Chicago Style (17th ed.) CitationNC, Wong, et al. "Phase III Trial of Intravenous Mannitol Versus Placebo During Nephron-sparing Surgery: Post Hoc Analysis of 3-yr Outcomes." European Urology Focus 5, no. 6 (2019): 977. https://doi.org/10.1016/j.euf.2019.04.003.
MLA (9th ed.) CitationNC, Wong, et al. "Phase III Trial of Intravenous Mannitol Versus Placebo During Nephron-sparing Surgery: Post Hoc Analysis of 3-yr Outcomes." European Urology Focus, vol. 5, no. 6, 2019, p. 977, https://doi.org/10.1016/j.euf.2019.04.003.